AA
WHWK

ALPS Advisors’s Whitehawk Therapeutics WHWK Stock Holding History

ALPS Advisors’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-18,094
Closed -$87.6K – 1019
2023
Q3 		$87.6K Buy
18,094
+129
+0.7% +$750 ﹤0.01% 971
2023
Q2 		$123K Buy
17,965
+1,891
+12% +$14.7K ﹤0.01% 986
2023
Q1 		$116K Sell
16,074
-468
-3% -$5K ﹤0.01% 996
2022
Q4 		$212K Buy
16,542
+5,033
+44% +$65.7K ﹤0.01% 993
2022
Q3 		$163K Sell
11,509
-914
-7% -$12K ﹤0.01% 1016
2022
Q2 		$153K Sell
12,423
-9,046
-42% -$134K ﹤0.01% 1007
2022
Q1 		$364K Sell
21,469
-2,705
-11% -$51.8K ﹤0.01% 593
2021
Q4 		$584K Buy
+24,174
New +$607K 0.01% 470

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ALPS Advisors's WHWK Position: Q4 2023 in Review

ALPS Advisors sold out of Whitehawk Therapeutics (WHWK) in Q4 2023, closing a stake of 18,094 shares — an estimated $87.6K sold.

ALPS Advisors first reported a position in WHWK in Q4 2021 and held it in 8 quarters. The position peaked at $584K in Q4 2021. 65 funds tracked by Wall St. Rank hold WHWK as of Q4 2023.

  • ALPS Advisors reported no remaining Whitehawk Therapeutics position as of Q4 2023 after selling out during the quarter.
  • ALPS Advisors sold 18,094 Whitehawk Therapeutics shares in Q4 2023, an estimated $87.6K.
  • ALPS Advisors first reported a position in Whitehawk Therapeutics in Q4 2021 and held it in 8 quarters.
  • ALPS Advisors's Whitehawk Therapeutics position peaked at $584K in Q4 2021.
  • 65 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q4 2023.

Based on ALPS Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.